SUPN
Supernus Pharmaceuticals, Inc.
A maker of brain and nervous-system medicines, Supernus develops and sells branded treatments for ADHD, Parkinson's disease, epilepsy, and postpartum depression—brands like Qelbree, GOCOVRI, Trokendi XR, and ZURZUVAE. It began in 2005 as a spin-out of Shire Laboratories, founded by Jack Khattar, who then bought the very business he had led. Its name comes from Latin for "from above," a fitting label for a company born out of the lab it once ran.
CUSIP: 868459108HealthcareUS1 holder
Total Value
$7.10M
Total Shares
152.7K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
